| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |